Understanding how to maintain research efforts during parental leave
Official title: Research Continuity During Parental Leave
Funded at University of California, San Francisco · NIH-11267409 · Data updated 2026-11-12
This study looks at how to keep important HIV prevention projects for young girls running smoothly while researchers take time off for parental leave, helping them manage their work better during this important time.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 10, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $50,000 |
| NIH project number | 3K01MH134775-02S1 |
| Project ID | NIH-11267409 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are female adolescents in impoverished areas who are at risk for HIV/AIDS.
✕Less likely to help
Patients who are not female adolescents or those not living in impoverished conditions may not receive direct benefits from this research.
What this research studies
This research investigates strategies to ensure that research activities continue effectively when researchers take parental leave. It focuses on the challenges faced by researchers, particularly those working on HIV prevention among female adolescents in impoverished areas. The approach includes data collection and management techniques to support ongoing projects and interventions during these critical periods. By addressing these issues, the research aims to empower researchers and improve the continuity of important health initiatives.
Why it matters
Potential benefit: If successful, this research could lead to improved support systems for researchers, ultimately enhancing HIV prevention efforts for vulnerable populations.
How similar studies have gone: While the specific focus on parental leave in research is novel, similar studies have shown success in improving research continuity and outcomes in other contexts.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Gichane, Margaret — University of California, San Francisco
- Study coordinator: Gichane, Margaret
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.